# Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery

> **NCT04246541** · PHASE3 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 48 (actual)

## Conditions studied

- Meniscus Tear, Tibial
- Pain, Postoperative
- Postoperative Complications
- Ketorolac Adverse Reaction
- Opioid Use

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Oxycodone-Acetaminophen

## Key facts

- **NCT ID:** NCT04246541
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-23
- **Primary completion:** 2021-09-12
- **Final completion:** 2021-09-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04246541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04246541, "Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04246541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*